LECTURES 61 & 62 - gastrointestinal protectant Flashcards

(66 cards)

1
Q

List systemically absorbed antacids

A

NaHCO3
CaCO3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List minimally absorbed antacids

A

Al(OH)3
Mg(OH)2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List antacid salts with high neutralizing capacity

A

NaHCO3
Al(OH)3
Mg(OH)2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

List antacid salts with moderate neutralizing capacity

A

CaCO3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

List the adverse effects of NaHCO3 as an antacid salt

A

Systemic alkalosis
Fluid retention
Excess gas (CO2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

List the adverse effects of CaCO3 as an antacid salt

A

Hypercalcemia
Kidney stones
Metabolic alkalosis
(CO2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

List the adverse effects of Al(OH)3 as an antacid salt

A

Constipation
Hypophosphatemia

If absorbed - encephalopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List the adverse effects of Mg(OH)3 as an antacid salt

A

Diarrhea

If absorbed - CNS toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the types of acid secretion that PPI’s are able to neutralize

A

PPI’s effectively block both nocturnal acid secretion && acid secretion stimulated by meals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the types of acid secretion that H2RA’s are able to neutralize

A

H2 antagonists are&raquo_space; at suppressing nocturnal acid secretion
vs. acid secretion stimulated by meals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the MOA of PPI’s

A
  • absorbed in the stomach & taken up by parietal cells (slow onset, ~1 hr)
  • activated by acidic pH in parietal cells (prodrugs)
  • Irreversibly inhibit H+/K+ ATPase
  • Long DOA (> 24 hr) due to covalent inhibition & slow turnover of proton pumps
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name a potential ADR of PPI’s

A

When hypergastrinemia occurs, it may result in rebound hypersecretion of gastric acid upon drug withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List examples of PPI’s

A

Benzimidazoles:

  • Esomeprazole (Nexium) → pursued S-enantiomer - more potent
  • Omeprazole (Prilosec) → racemic mixture - less potent
  • Lansoprazole (Prevacid)
  • Rabeprazole (Aciphex)
  • Pantoprazole (Protonix)
  • Dexlansoprazole (Dexilant)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the dosing regimen of Benzimidazoles

A

Dosed PO BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What class of drug is Esomeprazole (Nexium)?

A

Benzimidazoles - Proton Pump Inhibitors (PPI’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What class of drug is Omeprazole (Prilosec)?

A

Benzimidazoles - Proton Pump Inhibitors (PPI’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What class of drug is Lansoprazole (Prevacid)?

A

Benzimidazoles - Proton Pump Inhibitors (PPI’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What class of drug is Rabeprazole (Aciphex)?

A

Benzimidazoles - Proton Pump Inhibitors (PPI’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What class of drug is Pantoprazole (Protonix)?

A

Benzimidazoles - Proton Pump Inhibitors (PPI’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What class of drug is Dexlansoprazole (Dexilant)?

A

Benzimidazoles - Proton Pump Inhibitors (PPI’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What class of drug is Vonoprazan (Voquenza)?

A

K+-competitive acid blocker (P-CAB)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the binding of Vonoprazan (Voquenza)

A

reversible binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

List advantages of Vonoprazan (Voquenza)

A

Faster acid suppression
Not a prodrug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

List potential ADRs of Vonoprazan (Voquenza)

A

Acute tubulointerstitial nephritis
Skin reactions

(others are similar to PPI’s)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
List medications that act as mucosal protective agents
Sucralfate (Carafate) Misoprostol (Cytotec)
26
Describe the dosing of Misoprostol (Cytotec)
Dosed PO QID (used in combination with chronic NSAIDs)
27
Describe the dosing of Sucralfate (Carafate)
Dosed PO QID
28
Describe the MOA of Sucralfate (Carafate)
- Polymerizes & forms protective barrier at ulcer site - Acidic pH activates complex
29
Describe the MOA of Misoprostol (Cytotec)
- Reduced acid secretion (parietal cell) - Cytoprotectant effects (enhanced mucus & bicarbonate secretion)
30
List ways to detect an H. pylori infection associated with peptic ulcers
- 13/14C-labelled urea - H2N-CO-NH2 - PCR of stool sample
31
Describe why antibiotics may be considered for treatment of peptic ulcers
Many peptic ulcers are associated with infection of the gastric mucosa by Helicobacter pylori (gram-negative bacilli)
32
Name a medication that can be used to treat peptic ulcers caused by an H. pylori infection
Bismuth subsalicylate (pepto-bismol) -- as part of multi-drug therapy --
33
Describe the activity of Bismuth subsalicylate (pepto-bismol)
Antibacterial, antiviral & antisecretory activity
34
Describe the MOA of Bismuth subsalicylate (pepto-bismol)
Converted to bismuth salts & salicylic acid in the GI tract
35
Describe the uses of Bismuth subsalicylate (pepto-bismol)
Nausea, heartburn, indigestion, upset stomach, diarrhea Part of multi-drug therapy for H. pylori eradication
36
Describe the action of prokinetic drugs
increase GI motility
37
List examples of prokinetic drugs
- Metoclopramide (Reglan) - Prucalopride (Motegrity) - Tegaserod (Zelnorm) - Lubiprostone (Amatiza) - Linaclotide (Linzess) - Plecanatide (Trulance) - Tenapoanor (Ibrelsa)
38
Describe Metoclopramide (Reglan)
D2 dopamine receptor antagonist
39
Describe the MOA of Metoclopramide (Reglan)
- Blockade of D2 receptors in the myenteric plexus leads to increased ACh release - D2 receptor blockade also produces anti-emetic effects
40
List the clinical uses of Metoclopramide (Reglan)
- Promotes gastric emptying to facilitate small bowel intubation - Post-op & diabetic gastroparesis - GERD
41
List potential SE's of Metoclopramide (Reglan)
Can lead to acute dystonic (muscle contraction) reactions
42
Describe the MOA of 5HT4 receptor agonists
Activation leads to increased cAMP, PKA activation & release of ACh
43
List examples of 5HT4 receptor agonists
- Prucalopride (Motegrity) - Tegaserod (Zelnorm)
44
Describe the dosing for Prucalopride (Motegrity)
PO QD
45
Describe the dosing for Tegaserod (Zelnorm)
PO BID
46
Describe the indication for Prucalopride (Motegrity)
tx of chronic idiopathic constipation (CIC) in adults
47
Describe the indication for Tegaserod (Zelnorm)
treatment of IBS with constipation in women under 65
48
Describe the indication for Chloride Channel Activators
treatment of IBS + constipation
49
List examples of chloride channel activators
- Lubiprostone (Amatiza) - Linaclotide (Linzess) - Plecanatide (Trulance)
50
Describe the MOA for Lubiprostone (Amatiza)
Stimulation of type 2 chloride channel (CIC-2) activator in small intestine
51
Describe the dosing for Lubiprostone (Amatiza)
PO BID
52
Describe the MOA for Linaclotide (Linzess) & Plecanatide (Trulance)
Peptide activator of guanylate cyclase C (GC-C)
53
Describe the dosing for Linaclotide (Linzess) & Plecanatide (Trulance)
PO QD
54
Describe the MOA for Tenapoanor (Ibrelsa)
Na+/H+ exchanger inhibition: - The sodium/hydrogen exchanger (NHE3) is expressed on the luminal side of small bowel & colonic epithelial cells - NHE3 functions to absorb sodium from the luminal contents - Increased Na+ in the gut → increased water in the gut, which accelerates transit of intestinal contents
55
Describe the dosing for Tenapoanor (Ibrelsa)
PO BID
56
Describe the indications for Tenapoanor (Ibrelsa)
For IBS with constipation
57
Give examples of drug classes that reduce GI motility (antidiarrheals)
Opiates 5HT3 receptor antagonists
58
Describe the MOA for Opiates
Inhibition of presynaptic cholinergic nerves
59
Describe the MOA for 5HT3 receptor antagonists
- Blocks visceral afferent pain sensation & decreases colon motility - 5HT3 receptors are ion channels → activation is excitatory
60
List examples of opiates that act as antidiarrheals
Diphenoxylate -- active in the CNS Loperamide (Imodium) -- Poorly traverse the blood brain barrier -- Act locally to delay gastric emptying
61
Which nervous system affects the intrinsic primary afferent neuron for 5HT3 receptors
Enteric Nervous System (ENS) signaling
62
List effects caused by the extrinsic primary afferent (5HT3 receptors) & the nervous system that is associated
Nausea, vomiting, pain CNS signaling
63
List the effects of interneuron & motor neurons in the ENS for the 5HT3 receptors
Increased peristalsis
64
Given an example of a 5HT3 receptor antagonist
Alsosetron (Lotronex)
65
Name the indication of Alsosetron (Lotronex)
IBS with diarrhea
66
What is the dosing for Alsosetron (Lotronex)?
PO BID